Live from the NIH registry
Studies recruiting near Madison right now
Top 25 of 535 recruiting studies, sorted by proximity — each links to its official registry page
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
UW Health Comprehensive Program for Bleeding Disorders — Madison, Wisconsin (0.8 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
University of Wisconsin Carbone Cancer Center - University Hospital — Madison, Wisconsin (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Madison, Wisconsin (0.8 mi)
· Sponsor: Daiichi Sankyo
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma
Fractures, Bone
N/A
Observational 200 participants sought
SSM Health St. Mary's Hospital — Madison, Wisconsin (0.8 mi)
· Sponsor: Artoss Inc.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
SSM Health Dean Medical Group ( Site 0106) — Madison, Wisconsin (0.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
University of Wisconsin - Carbone Cancer Center — Madison, Wisconsin (0.8 mi)
· Sponsor: C4 Therapeutics, Inc.
Implementation of an Accessible Healthcare Model (ACHD STRONG): Comparing Nurse and Physician Lead Healthcare Transition Education in a RE-AIM Framework
Congenital Heart Disease
N/A
Interventional 450 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Resistant Potato Starch to Alleviate GWI
Gulf War Illness
Phase 2
Interventional 52 participants sought
William S. Middleton Memorial Veterans Hospital, Madison, WI — Madison, Wisconsin (0.8 mi)
· Sponsor: VA Office of Research and Development
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: Nicole Hamblett
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Breast Cancer
Phase 1
Interventional 392 participants sought
Wisconsin Institute for Medical Research — Madison, Wisconsin (0.8 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Madison, Wisconsin (0.8 mi)
· Sponsor: Sameek Roychowdhury
Well-being Skills for Reentry
Formerly Incarcerated Adults
N/A
Interventional 60 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi)
· Sponsor: Pfizer
Electrophysiology of Fetal Arrhythmia
Fetal Arrhythmia
N/A
Observational 450 participants sought
University of Wisconsin-Madison — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Randomized Trial of SGLT2i in Heart Transplant Recipients
Heart Transplant, Cardiovascular Disease
Phase 4
Interventional 200 participants sought
William S. Middleton Memorial Veterans Hospital, Madison, WI — Madison, Wisconsin (0.8 mi)
· Sponsor: VA Office of Research and Development
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Madison, Wisconsin (0.8 mi)
· Sponsor: AstraZeneca
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: Kura Oncology, Inc.
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical ( Site 0048) — Madison, Wisconsin (0.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 2
Healthy
N/A
Interventional 48 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants
Healthy Volunteers
Phase 1
Interventional 10 participants sought
Fortrea Clinical Research Unit Inc. — Madison, Wisconsin (0.8 mi)
· Sponsor: Eisai Inc.
PCOS and Brain Health
PCOS
N/A
Observational 45 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
Phase 1
Interventional 272 participants sought
University of Wisconsin Carbone Cancer Center — Madison, Wisconsin (0.8 mi)
· Sponsor: Janux Therapeutics